FT596 in Combination With R-CHOP in Subjects With B-Cell Lymphoma

Clinical trial NCT05934097 · WITHDRAWN

Trial details

NCT number: NCT05934097
Sponsor: Fate Therapeutics
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma Transformed Indolent Non-Hodgkin's Lymphoma Follicular Lymphoma Mantle Cell Lymphoma Marginal Zone Lymphoma

Start date: 2022-12-01
Primary completion: 2026-05-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.